BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc., today announced the closing of its initial public offering of 11,499,999 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,499,999 shares of common stock. Aimmune’s common stock began trading on The NASDAQ Global Select Market on August 6, 2015, under the symbol AIMT.
Help employers find you! Check out all the jobs and post your resume.
